And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | July 9, 2020

Leo Pharma: FDA Accepts BLA for Tralokinumab for AD

The FDA has accepted the Biologics License Application (BLA) for Leo Pharma’s tralokinumab for the treatment of adults with moderate-to-severe atopic dermatitis (AD), the company says. A taget action date has been set in the second...

Read More

News | July 9, 2020

New Infographic Compare Rashes to COVID Toes

A new infographic from First Derm compares and contrasts rashes associated with COVID-19.

Read More

News | July 9, 2020

Allergan Helps Bridge the Gender Gap in STEM

Allergan has pledged $300K to support STEM Education through their partnership with Girls Inc.  In addition to the donation, Allergan is also offering mentoring initiatives and resources to educate and empower future female leaders...

Read More

News | July 9, 2020

Skin of Color Update Goes Virtual for 2020

Skin of Color Update’s 2020 event is going virtual. The largest medical education event focused on the dermatologic treatment of skin of color will be held September 12-13. The Skin of Color Update agenda has been...

Read More
DermWireTV: Qwo Approved, Assessing Resident Anxiety thumbnail
Play Button

DermWireTV: Qwo Approved, Assessing Resident Anxiety

Series: DermWire TV | July 9, 2020

FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. Allergan’s CoolSculpting is celebrating 10 years on the market.

Watch Video

Advertisement

The Latest News

Advertisement

View more